Sperm Bank Market by Donor Type (ID Disclosure Donors, Known Donor, and Anonymous Donor), Vial Type (Intracervical Insemination (ICI), Intrauterine Insemination (IUI), and In-Vitro Fertilization (IVF)), and Service (Donor Screening (Genetic Screening), Specimen Storage, Semen Analysis, and Other Services): Global Market Size Estimates and Forecast (2022-2030)

Code: BMIRE00026798 | Pages: 100 | Industry: Biotechnology | Date: Oct 2022 | Type: Global

The market crossed US$ 5586.23 million mark in 2022 and is expected to hit US$ 8791.03 million by 2030, recording a CAGR of 5.8% during the forecast period.

Increasing prevalence of infertility to support the market growth.

Growing concerns of male infertility due to abnormal and inadequate sperm volume and ejaculatory issues is projected to drive the demand for sperm bank services. According to the American Association of Pregnancy, male infertility accounts for 30% of infertility cases, which is around one-fifth of all infertility cases. One in 4 couples in developing countries are affected by infertility, and about 48.5 million couples experience infertility worldwide. As per an article published in July 2022, titled "Male Infertility", infertility affects 15% of all couples in the United States, 9% in Australia, and 8% to 12% in Eastern Europe. Other factors that cause male infertility include exposure to toxic substances, frequent alcohol consumption, illicit drugs, and smoking. Thus, the growing prevalence of male infertility worldwide is propelling the adoption of infertility services, thereby driving market growth. The known donor segment is expected to pace up due to changing legal landscape in various countries, including Switzerland, New Zealand, Sweden, the UK, and Australia. According to New Hampshire Fertility Law PLLC; under New Hampshire law, the use of a known donor can be a reasonable alternative for the parents after meeting all the legal prerequisites. In addition, it also ensures the availability of the medical and behavioral background of the donor.

Within the report, the market is segmented into donor type, vial type, service, and geography. By donor type, the market is further segmented into ID disclosure donors, known donor, and anonymous donor. By vial type, the market is categorized into intracervical insemination (ICI), intrauterine insemination (IUI), and in-vitro fertilization (IVF). Based on service, the market is divided into donor screening (genetic screening), specimen storage, semen analysis, and other services. Geographically, the market is sub segmented into North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa.

North America to offer lucrative opportunity to the market.

North America holds the largest market share in the sperm bank market. Due to growing acceptance of same-sex relationships and single parenthood in the region, it holds the largest share over the forecast period. In addition, rising disposable income motivates infertile couples to choose IVF treatments, and assisted reproductive technology (ART) also accelerate market growth. According to the US Centers for Disease Control and Prevention (CDC), approximately 1.9% of all US infants are born using ART technique. Moreover, advancements in technology and increasing company strategic activities are also contributing to the market growth. For instance, in February 2021, Generate Life Sciences expanded in Canada, with the introduction of California Cryobank. Therefore, owing to aforementioned factors, the market is expected to grow significantly in the region during the forecast period.

 

Semen analysis segment to witness significant growth during the forecast period.

Rising infertility in men owing to various reasons, such as changing lifestyles, underlying conditions, and others, growing government initiatives, and rising company activities favor the growth of the market. According to an article published by the Facts, Views, and Vision, Issues in Obstetrics, Gynecology and Reproductive Health in March 2021, titled "Simplified sperm testing devices: a possible tool to overcome lack of accessibility and inconsistency in male factor infertility diagnosis. An opportunity for low- and middle- income countries", stated that YO, SEEM, and ExSeed, a smartphone-based device helps to accurately measures volume, sperm concentration (millions/ml), and total motile sperm count. In addition, rising company's focus on developing and launching testing kits for analyzing sperm quality is expected to increase the demand for semen analysis, thereby boosting the market growth. For instance, in June 2021, Janani launched a first-of-its-kind at-home semen testing kit. The company has also developed a unique media that stores a sample without any damage to the sperms for up to 8 hours in non-laboratory conditions.

 

Recent strategic developments in sperm bank market

The sperm bank market has undergone several significant developments, and a few of these have been mentioned below:

  • In September 2019, Aytu BioScience, Inc. MiOXSYS, the company’s first-in-class seminal oxidative stress test for the assessment of male infertility, is available in South Africa and is offered through Androcryos, the largest sperm bank on the African continent.
  • In May 2022, Legacy, a digital fertility clinic for people with sperm, raised a US$ 25M Series B funding round with participation from FirstMark Capital, TQ Ventures, and Valor Equity Partners. With the funding, Legacy intended to quadruple its staff and expand its services beyond sperm testing and fertility assistance.

 

The sperm bank market is driven by several players by implementing strategic activities such as investments, new launches, mergers & acquisitions, and partnerships. California Cryobank, LLC; Fairfax Cryobank, INC; London Sperm Bank, Androcryos, Indian Spermtech, European Sperm Bank, Xytex Corporation; Cryos; Nordic Cryobank Group ApS are among the prominent players operating in the market.

Target audience for the report:

  • Sperm bank service providers
  • Associations, organizations, forums, and alliances
  • Government bodies, such as regulating authorities and policy makers
  • Venture capitalists, private equity firms, and start-up companies
  • Sperm bank suppliers and distributors
  • Research institutes, organizations, and consulting companies

Scope of the report:

In this report, the market has been segmented based on:

  • Donor Type:
    • ID Disclosure Donors
    • Known Donor
    • Anonymous Donor
  • Vial Type:
    • Intracervical Insemination (ICI)
    • Intrauterine Insemination (IUI)
    • In-Vitro Fertilization (IVF)
  • Service:
    • Donor Screening (Genetic Screening)
    • Specimen Storage
    • Semen Analysis
    • Other Services
  • Region
    • North America
    • Europe
    • Asia Pacific (APAC)
    • South & Central America
    • Middle East & Africa
  • Companies profiled
    • California Cryobank, LLC
    • Fairfax Cryobank, INC
    • London Sperm Bank
    • Androcryos
    • Indian Spermtech
    • European Sperm Bank
    • Xytex Corporation
    • Cryos
    • Nordic Cryobank Group ApS
    • Baby Quest Cryobank Pvt. Ltd.

The List of Companies
- California Cryobank, LLC
- Fairfax Cryobank, INC
- London Sperm Bank
- Androcryos
- Indian Spermtech
- European Sperm Bank
- Xytex Corporation
- Cryos
- Nordic Cryobank Group ApS
- Baby Quest Cryobank Pvt. Ltd.

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$2000
Site License
$3000
Enterprise License
$4000